-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to provide investment results that, before expenses, generally correspond to the price and yield performance of the S&P MidCap 400? Index?. The Trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the ?Portfolio?), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index. The index is composed of four hundred (400) selected stocks, all of which are listed on national stock exchanges, and span a broad range of major industry groups.
Company Website : www.spdrs.com
Currency: USD
Country : USA
Inception Date: 04/05/1995
Primary Benchmark: S&P MidCap 400 TR
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.25%
Management Expense Ratio: 0.24 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 0.70 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SOJE | SOJE | 0.00 % |
+0.70 (+3.66%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
+0.44 (+0.79%) |
USD 32.43B |
| DTB | DTB | 0.00 % |
+1.19 (+6.19%) |
USD 26.58B |
| DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
+0.36 (+1.19%) |
USD 26.00B |
| GBTC | Grayscale Bitcoin Trust (BTC) | 0.00 % |
-0.05 (-0.08%) |
USD 23.75B |
| JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.73B |
| SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.01 (+0.01%) |
USD 19.79B |
| AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
+1.53 (+1.72%) |
USD 10.49B |
| DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.37 (+0.94%) |
USD 10.15B |
| DFAT | Dimensional U.S. Targeted Valu.. | 0.00 % |
+0.59 (+1.15%) |
USD 9.40B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| LEXI | Alexis Practical Tactical.. | 5.46 % | 0.00 % |
+0.27 (+0.98%) |
USD 0.08B |
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 17.37% | 71% | C- | 64% | D | ||
| Dividend Return | 0.73% | 29% | F | 20% | F | ||
| Total Return | 18.10% | 70% | C- | 61% | D- | ||
| Trailing 12 Months | |||||||
| Capital Gain | -2.16% | 37% | F | 45% | F | ||
| Dividend Return | 0.90% | 21% | F | 14% | F | ||
| Total Return | -1.26% | 34% | F | 41% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 38.30% | 79% | B- | 76% | C+ | ||
| Dividend Return | 7.11% | 34% | F | 25% | F | ||
| Total Return | 45.40% | 77% | C+ | 72% | C | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.44% | 77% | C+ | 61% | D- | ||
| Dividend Return | 8.74% | 69% | C- | 59% | D- | ||
| Total Return | 1.30% | 42% | F | 34% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 10.56% | 38% | F | 85% | B | ||
| Risk Adjusted Return | 82.74% | 54% | F | 89% | A- | ||
| Market Capitalization | 18.13B | 98% | N/A | 90% | A- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
